The TRPV1 channel has become a potentially relevant target for metabolic intervention, including insulin resistance, obesity, type 2 diabetes, and nonalcoholic fatty liver, due to its presence in a variety of metabolic tissues. Here, TRPV1 is linked to obesity due to melanocortin 4 receptor deficiency.